Spatial metabolomics on liver cirrhosis to hepatocellular carcinoma progression

被引:0
|
作者
Michelle Junyi He
Wenjun Pu
Xi Wang
Xiaoni Zhong
Dong Zhao
Zhipeng Zeng
Wanxia Cai
Jiayi Liu
Jianrong Huang
Donge Tang
Yong Dai
机构
[1] The Second Clinical Medical College of Jinan University,Clinical Medical Research Center
[2] Shenzhen People’s Hospital,Department of Biology, Department of Brain and Cognitive Sciences
[3] Massachusetts Institute of Technology,The First Affiliated Hospital
[4] Jinan University,The First Affiliated Hospital (Shenzhen People’s Hospital)
[5] Southern University of Science and Technology,Department of Nephrology Center, Department of Liver Transplant Center, The Third People’s Hospital of Shenzhen
[6] The Second Affiliated Hospital of Southern University of Science and Technology,Guangxi Key Laboratory of Metabolic Disease Research
[7] Central Laboratory of Guilin,undefined
[8] 924St Hospital,undefined
来源
关键词
Spatial metabolomics; Liver cirrhosis; Hepatocellular carcinoma; Disease progression; Amino acid metabolism;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Spatial metabolomics on liver cirrhosis to hepatocellular carcinoma progression
    He, Michelle Junyi
    Pu, Wenjun
    Wang, Xi
    Zhong, Xiaoni
    Zhao, Dong
    Zeng, Zhipeng
    Cai, Wanxia
    Liu, Jiayi
    Huang, Jianrong
    Tang, Donge
    Dai, Yong
    CANCER CELL INTERNATIONAL, 2022, 22 (01)
  • [2] Cell Differentiation Trajectory in Liver Cirrhosis Predicts Hepatocellular Carcinoma Prognosis and Reveals Potential Biomarkers for Progression of Liver Cirrhosis to Hepatocellular Carcinoma
    He, Zhaobin
    Peng, Cheng
    Li, Tianen
    Li, Jie
    FRONTIERS IN GENETICS, 2022, 13
  • [3] Utilization of metabolomics to identify serum biomarkers for hepatocellular carcinoma in patients with liver cirrhosis
    Ressom, Habtom W.
    Xiao, Jun Feng
    Tuli, Leepika
    Varghese, Rency S.
    Zhou, Bin
    Tsai, Tsung-Heng
    Ranjbar, Mohammad R. Nezami
    Zhao, Yi
    Wang, Jinlian
    Di Poto, Cristina
    Cheema, Amrita K.
    Tadesse, Mahlet G.
    Goldman, Radoslav
    Shetty, Kirti
    ANALYTICA CHIMICA ACTA, 2012, 743 : 90 - 100
  • [4] The role of the gut microbiome in the development and progression of liver cirrhosis and hepatocellular carcinoma
    Roderburg, Christoph
    Luedde, Tom
    GUT MICROBES, 2014, 5 (04) : 441 - 445
  • [5] Screening of the Key Genes for the Progression of Liver Cirrhosis to Hepatocellular Carcinoma Based on Bioinformatics
    Chen, Yuanbin
    Qian, Hongyan
    He, Xiao
    Zhang, Jing
    Xue, Song
    Wu, Yumeng
    Chen, Jian
    Wu, Xuming
    Zhang, Suqing
    JOURNAL OF ONCOLOGY, 2022, 2022
  • [6] Angiogenesis in liver cirrhosis and hepatocellular carcinoma
    Amarapurkar, Anjali D.
    Vibhav, V. Kim
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2008, 51 (03) : 323 - 328
  • [7] Liver transplantation for hepatocellular carcinoma in cirrhosis
    Fassati, LR
    Rossi, G
    Mazzaferro, V
    Forti, D
    Regalia, E
    Belli, LS
    Colella, G
    Caccamo, L
    HAMBURG '97 - EUROPEAN I.H.P.B.A. CONGRESS, 1997, : 303 - 309
  • [8] Profiling of plasma metabolomics in patients with hepatitis C-related liver cirrhosis and hepatocellular carcinoma
    Nomair, Azhar Mohamed
    Madkour, Marwa Ahmed
    Shamseya, Mohammed Mohammed
    Elsheredy, Heba Gaber
    Shokr, Ahmed
    CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2019, 5 (04) : 317 - 326
  • [9] Biomarker Discovery for Hepatocellular Carcinoma in Patients with Liver Cirrhosis Using Untargeted Metabolomics and Lipidomics Studies
    Rashid, Md Mamunur
    Varghese, Rency S.
    Ding, Yuansong
    Ressom, Habtom W.
    METABOLITES, 2023, 13 (10)
  • [10] UTILIZATION OF METABOLOMICS TO IDENTIFY SERUM BIOMARKERS FOR HEPATOCELLULAR CARCINOMA (HCC) IN PATIENTS WITH LIVER CIRRHOSIS (LC)
    Ressom, Habtom W.
    Xiao, Jun Feng
    Tuli, Leepika
    Varghese, Rency S.
    Zhou, Bin
    Tsai, Tsung-Heng
    Ranjbar, Mohammad R. Nezami
    Cheema, Amrita K.
    Goldman, Radoslav
    Shetty, Kirti
    HEPATOLOGY, 2011, 54 : 1373A - 1374A